Skip to main content
54°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Geron Corp
(NQ:
GERN
)
3.810
-0.090 (-2.31%)
Official Closing Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Geron Corp
< Previous
1
2
3
4
5
6
7
8
9
Next >
A Preview Of Geron's Earnings
May 10, 2023
Via
Benzinga
Geron to Announce First Quarter 2023 Financial Results on May 11, 2023
May 04, 2023
From
Geron Corporation
Via
Business Wire
Geron Announces Upcoming Oral Presentation at 2023 American Society of Clinical Oncology Annual Meeting of Imetelstat Data from IMerge Phase 3 Lower Risk MDS Trial
April 26, 2023
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 20, 2023
From
Geron Corporation
Via
Business Wire
Looking Into Geron's Return On Capital Employed
March 17, 2023
Via
Benzinga
The Latest Analyst Ratings for Geron
March 17, 2023
Via
Benzinga
Geron (GERN) Q4 2022 Earnings Call Transcript
March 16, 2023
GERN earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Why Shares of Geron Are Up 30% This Week
April 20, 2023
The company's CEO was scheduled to speak at a virtual conference on Thursday.
Via
The Motley Fool
Geron to Present at Upcoming Investor Conferences in April
April 12, 2023
From
Geron Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023
March 28, 2023
Via
Benzinga
7 Biotech Stocks Sitting in the Sweet Spot
March 24, 2023
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable.
Via
InvestorPlace
Earnings Outlook For Geron
March 15, 2023
Via
Benzinga
2 Top Healthcare Stocks to Buy Right Now
February 13, 2023
One has a breakout drug, the other a nice-sized moat.
Via
The Motley Fool
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 16, 2023
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Milestones
March 16, 2023
From
Geron Corporation
Via
Business Wire
Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023
March 09, 2023
From
Geron Corporation
Via
Business Wire
SMID Cap Life Science Update: Are You An Investor Or Trader?
February 20, 2023
Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows.
Via
Talk Markets
7 A-Rated Penny Stocks Worth Betting On
February 19, 2023
Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance.
Via
InvestorPlace
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 16, 2023
From
Geron Corporation
Via
Business Wire
7 A-Rated Healthcare Stocks to Buy for the Future of Medicine
February 12, 2023
Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio.
Via
InvestorPlace
7 A-Rated Stocks to Buy for February 2023
February 07, 2023
Now's the time to pounce on these seven high-quality stocks to buy; each one earns an A rating in Portfolio Grader.
Via
InvestorPlace
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
February 05, 2023
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?
Via
Talk Markets
7 A-Rated Stocks to Buy for Less Than $25
January 24, 2023
These seven stocks to buy for less than $25 per share are strong opportunities in today's resilient yet uncertain market.
Via
InvestorPlace
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 19, 2023
From
Geron Corporation
Via
Business Wire
Geron to Present at the B. Riley Securities 3rd Annual Virtual Oncology Conference
January 12, 2023
From
Geron Corporation
Via
Business Wire
Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S.
January 11, 2023
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Plus Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $227.8 Million
January 10, 2023
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces Pricing of $198 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
January 05, 2023
From
Geron Corporation
Via
Business Wire
Exclusive: 5 Stocks To Watch From Benzinga Moneymaker Index, One Large Cap And 4 Small Cap Names
January 05, 2023
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities.
Via
Benzinga
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 05, 2023
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.